Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

CATX Perspective Therapeutics Inc

3,81

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:12:33

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Perspective Therapeutics (AMEX:CATX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Perspective Therapeutics Charts.

Perspective Therapeutics (AMEX:CATX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Perspective Therapeutics Charts.

News Perspective Therapeutics Inc

Form 8-K - Current report
Freitag 24 Januar 2025 (7 Tage vor) • Edgar (US Regulatory)

Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium
Freitag 24 Januar 2025 (7 Tage vor) • GlobeNewswire Inc.

Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025
Mittwoch 22 Januar 2025 (1 Woche vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 13 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Montag 13 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Freitag 10 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 7 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 6 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial Officer
Montag 6 Januar 2025 (4 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 6 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 4 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Perspective Therapeutics Inc News-Artikel

Empresa Distribuidora Y ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen